GEDpm-cg
GEDpm-cg designs in-silico genomic single-nucleotide point mutations in Corynebacterium glutamicum to support precise genome editing workflows using suicide plasmid-mediated counter-selection and overlap-based DNA assembly for vector construction and experimental verification.
Key Features:
- Comprehensive design capability: Generates precise designs for single-nucleotide edits at any locus on the C. glutamicum chromosome using a suicide plasmid-mediated counter-selection strategy combined with overlap-based DNA assembly.
- High-throughput in-silico processing: Performs computational design tasks for over 10,000 single point mutations in approximately five minutes.
- Primer and verification design: Produces primer sequences for overlap-based vector DNA assembly and for sequencing verification of edits.
- Experimental validation: In-silico designs were validated by successful construction of three independent point mutations in C. glutamicum.
Scientific Applications:
- Microbial cell factory development: Enables targeted genomic modifications in C. glutamicum for strain engineering.
- Metabolic engineering: Supports precise single-nucleotide changes to optimize metabolic pathways.
- Synthetic biology: Facilitates design and verification of genetic variants and engineered constructs.
- Industrial strain optimization: Supports large-scale mutation analysis for industrial applications using C. glutamicum.
Methodology:
Uses computer-aided design tools to generate in-silico designs for suicide plasmid-mediated counter-selection, overlap-based DNA assembly for vector construction, and primer sequences for assembly and sequencing verification.
Topics
Details
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 5/8/2022
- Last Updated:
- 5/8/2022
Operations
Publications
Yang Y, Mao Y, Liu Y, Wang R, Lu H, Li H, Luo J, Wang M, Liao X, Ma H. GEDpm-cg: Genome Editing Automated Design Platform for Point Mutation Construction in Corynebacterium glutamicum. Frontiers in Bioengineering and Biotechnology. 2021;9. doi:10.3389/fbioe.2021.768289. PMID:34722482. PMCID:PMC8554027.